SLC16A1 and Miyoshi myopathy: Su et al. showed that CD147 silencing could not only suppress MM cell proliferation and invasion, but also inhibited the production of VEGF in MM cells via downregulation of monocarboxylate transporters (MCT) 1 and MCT4.